Regulatory Updates
🇺🇸 FDA Page 18FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 205–216 of 382 articles
Resilience and Reinvention: Biotech’s Year of Maturity
Global M&A Trends in Health Industries: 2026 Outlook
Wockhardt Secures US FDA Approval for ZAYNICH: A Milestone for Indian Pharma
Replimune's Third FDA Approval Attempt and Pfizer's China Deal
altRx GLP-1 Review 2026: FDA Updates on Semaglutide
Friday Five: Key Regulatory Updates in Pharma
Zydus Lifesciences Secures FDA Priority Review for Liver Disease Drug
Longeveron Reports Q1 2026 Financial Results and Business Update
Pennsylvania Compounding Pharmacy Receives FDA Warning Letter
Chinese Pharma Innovators Expand Globally with Innovative Deal Structures
Eli Lilly's $3.8B Investment in Infectious Disease Portfolio
FDA's New Guidance on AI: Regulatory Restraint Explained